Organization and Basis of Presentation (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Accumulated deficit | $ (65,700,000) | |
| Cash and cash equivalents | 3,200,000 | |
| Net Cash Used In Operation | 11,100,000 | |
| Gross proceeds from issuance of common stock & warrants | 6,886,102 | $ 7,605,625 |
| January 2025 [Member] | ||
| Gross proceeds from issuance of common stock & warrants | $ 2,600,000 | |
| X | ||||||||||
- Definition Amount of cumulative earnings (deficits) for relevant time periods. No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash equivalents restricted as to withdrawal or usage. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|